New compound offers superior therapeutic approach to treat MS

Previous studies have shown that estrogens and estrogen-like compounds reduce multiple sclerosis-like inflammation and disability in mice. At first glance these treatments appear promising, but they carry a host of negative side effects, from feminizing male mice to increasing the risk of cancer, heart disease and stroke. An interdisciplinary team of scientists have piggy-backed on this approach with a new concept that side steps the negative side effects while alleviating symptoms.

Leave a Reply

Your email address will not be published. Required fields are marked *